Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Dec 31, 2023
Revenue in the quarter moved higher compared to the immediately preceding period, reversing the prior sequential decline. Despite this improvement, revenue remained lower than the same quarter one year ago, continuing the year-over-year contraction seen in recent periods.
Key takeaway
Quarter ended Dec 31, 2023 · FY2023 Q4
Revenue in the quarter moved higher compared to the immediately preceding period, reversing the prior sequential decline. Despite this improvement, revenue remained lower than the same quarter one year ago, continuing the year-over-year contraction seen in recent periods.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.9B
Revenue reported for this quarter.
Quarter-over-quarter
+3.0%
Change from the immediately preceding quarter.
Year-over-year
-4.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$42.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Apr 1, 2023 | $10.7B | -9.4% |
| Jul 1, 2023 | $10.7B | -2.6% |
| Sep 30, 2023 | $10.6B | -1.0% |
| Dec 31, 2023 | $10.9B | -4.9% |
Revenue performance
The reported revenue direction for this quarter was up from the prior quarter, but down from the same quarter one year earlier.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased. Compared with the same quarter one year earlier, revenue decreased.
What to watch
The filing context does not provide a specific reason for the year-over-year revenue decline in this quarter.